Sign In
Buy MGTA
$0.700
+0 (+0%)
At Close: Dec 08, 2023
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune and blood systems reset
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplant to more pa
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Magenta Therapeutics (NASDAQ: MGTA) and bluebird bio, Inc. (NASDAQ: BLUE) today announced an exclusive clinical trial collaboration to evaluate the utility of MGTA-1
34,200 Shares in Magenta Therapeutics Inc (NASDAQ:MGTA) Acquired by Tudor Investment Corp Et Al
07:26am, Friday, 18'th Sep 2020
Tudor Investment Corp Et Al bought a new position in shares of Magenta Therapeutics Inc (NASDAQ:MGTA) during the second quarter, according to its most recent Form 13F filing with the SEC. The fund bou
The Low Down On Magenta Therapeutics
07:01am, Monday, 31'st Aug 2020
Busted IPO Magenta Therapeutics, Inc. executed a late-June secondary at $8, shortly after announcing it was abandoning a Phase 2 trial due to enrollment challenges.
3 Healthcare Stocks Under $10 With Massive Upside Ahead
07:30pm, Thursday, 13'th Aug 2020
Which stocks are leading the pack out on Wall Street? Biotechs. Understandably, investors have taken a more cautious approach when navigating the confused financial environment, but focus is locking i
Magenta Therapeutics Reports Recent Business Highlights and Second Quarter Financial Results
12:00pm, Thursday, 06'th Aug 2020
Magenta Therapeutics (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune reset to more patients, today reported recent business high
Magenta Therapeutics Reports Recent Business Highlights and Second Quarter Financial Results
12:00am, Thursday, 06'th Aug 2020
Magenta Therapeutics (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune reset to
Here's What Magenta Therapeutics, Inc.'s (NASDAQ:MGTA) Shareholder Ownership Structure Looks Like
12:28pm, Tuesday, 04'th Aug 2020
A look at the shareholders of Magenta Therapeutics, Inc. (NASDAQ:MGTA) can tell us which group is most powerful...
Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in August
08:05pm, Monday, 03'rd Aug 2020
Magenta Therapeutics (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune reset to more patients, today announced that the company wi
Magenta Therapeutics (NASDAQ:MGTA) Downgraded to Sell at BidaskClub
05:12am, Monday, 03'rd Aug 2020
Magenta Therapeutics (NASDAQ:MGTA) was downgraded by research analysts at BidaskClub from a “hold” rating to a “sell” rating in a research note issued to investors on Saturday, BidAskClub repo
Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in August
12:00am, Monday, 03'rd Aug 2020
Magenta Therapeutics (Nasdaq: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune reset to
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Magenta Therapeutics, Inc. - MGTA
11:58pm, Wednesday, 15'th Jul 2020
NEW YORK, July 15, 2020 -- Pomerantz LLP is investigating claims on behalf of investors of Magenta Therapeutics, Inc. (“Magenta” or the “Company”) (NASDAQ: MGTA). Such.
Here is What Hedge Funds Think About Magenta Therapeutics, Inc. (MGTA)
07:44pm, Wednesday, 08'th Jul 2020
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that sm
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Magenta Therapeutics, Inc. - MGTA
09:10pm, Monday, 06'th Jul 2020
NEW YORK, NY / ACCESSWIRE / July 6, 2020 / Pomerantz LLP is investigating claims on behalf of investors of Magenta Therapeutics, Inc. ("Magenta" or the "Company") (NASDAQ:MGTA). Such ...
